Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open- Label Extension Study

被引:0
作者
Riedl, Marc [1 ]
Anderson, John [2 ]
Arcoleo, Francesco [3 ]
Cancian, Mauro [4 ]
Chapdelaine, Hugo [5 ]
Conlon, Niall [6 ,7 ]
Eren, Efrem [8 ]
Gompels, Mark [9 ]
Grigoriadou, Sofia [10 ]
Guarino, Maria [11 ]
Gurugam, Padmalal [12 ]
Kinaciyan, Tamar [13 ]
Magerl, Markus [14 ,15 ]
Manning, Michael [16 ]
Stobiecki, Marcin [17 ]
Tarzi, Michael [18 ]
Valerieva, Anna [19 ]
Wedner, H. James [20 ]
Yang, William [21 ]
Zanichelli, Andrea [22 ,23 ]
Crabbe, Rafael
Mulders, Susan
Levy, Jonathan [24 ]
Freudensprung, Ulrich [25 ]
Katbeh, Umar [25 ]
Knolle, Jochen [26 ]
Lesage, Anne [27 ]
Lu, Peng [24 ]
Aygoeren-Puersuen, Emel
机构
[1] Univ Calif La Jolla, La Jolla, CA USA
[2] AllerVie Hlth, Clin Res Ctr Alabama, Birmingham, AL USA
[3] UOC Patol Clin & Immunol, AOR Villa Sofia Cervello, Palermo, Italy
[4] Univ Hosp Padua, Padua, Italy
[5] UQAC, Chicoutimi, PQ, Canada
[6] St Jamess Hosp & Trinity Coll, Dublin, Ireland
[7] Wellcome Trust CRF, Trinity Coll, Dublin, Ireland
[8] Univ Hosp Southampton NHS Fdn Trust, Southampton, England
[9] North Bristol NHS Trust, Bristol, England
[10] Barts Hlth NHS Trust, London, England
[11] Osped Civitanova Marche, Civitanova Marche, Italy
[12] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[13] Med Univ Vienna, Vienna, Austria
[14] Charite, Berlin, Germany
[15] Fraunhofer ITMP Immunol & Allergol, Berlin, Germany
[16] Allergy Asthma & Immunol Associates Ltd, Scottsdale, AZ USA
[17] Jagiellonian Univ Med Coll, Krakow, Poland
[18] Univ Hosp Sussex NHS Fdn Trust, Brighton, England
[19] Med Univ Sofia, Dept Allergol, Sofia, Bulgaria
[20] Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO USA
[21] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[22] Univ Milan, Milan, Italy
[23] IRCCS, Policlin San Donato, Milan, Italy
[24] Pharvaris Inc, Lexington, MA USA
[25] Pharvaris GmbH, Zug, Switzerland
[26] JCK Consult, Frankfurt, Germany
[27] GrayMatters Consulting, Schilde, Belgium
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
600
引用
收藏
页码:AB194 / AB194
页数:1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
    Adams, David
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Wixner, Jonas
    Kristen, Arnt, V
    Schmidt, Hartmut H.
    Berk, John L.
    Losada Lopez, Ines Asuncion
    Dispenzieri, Angela
    Quan, Dianna
    Conceicao, Isabel M.
    Slama, Michel S.
    Gillmore, Julian D.
    Kyriakides, Theodoros
    Ajroud-Driss, Senda
    Waddington-Cruz, Marcia
    Mezei, Michelle M.
    Plante-Bordeneuve, Violaine
    Attarian, Shahram
    Mauricio, Elizabeth
    Brannagan, Thomas H., III
    Ueda, Mitsuharu
    Aldinc, Emre
    Wang, Jing Jing
    White, Matthew T.
    Vest, John
    Berber, Erhan
    Sweetser, Marianne T.
    Coelho, Teresa
    LANCET NEUROLOGY, 2021, 20 (01) : 49 - 59
  • [32] LONG-TERM SAFETY AND EFFICACY OF FITUSIRAN PROPHYLAXIS IN A PHASE 1/2 OPEN-LABEL EXTENSION STUDY IN PEOPLE WITH MODERATE OR SEVERE HEMOPHILIA A OR B
    Pipe, Steven W.
    Lissitchkov, Toshko
    Mangles, Sarah
    Georgiev, Pencho
    Feng, Erin
    Menapace, Laurel A.
    Kichou, Salim
    Andersson, Shauna
    Demissie, Marek
    Ragni, Margaret
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 100 : 99 - 100
  • [33] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
  • [34] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [35] Long-term efficacy and safety of switching from adalimumab to risankizumab: results from the open label extension LIMMitless
    Reich, Kristian
    Ryan, Caitriona
    Crowley, Jeffrey
    Szepietowski, Jacek C.
    Zeng, Jiewei
    Valdes, Joaquin
    Photowala, Huzefa
    Kaufmann, Christian
    Gooderham, Melinda
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 19 - 20
  • [36] Garadacimab For Hereditary Angioedema Prophylaxis In Adolescents: Efficacy And Safety From The Phase 3 (VANGUARD) Study And Open-Label Extension (Second Interim Analysis)
    Jacobs, Joshua
    Magerl, Markus
    Martinez-Saguer, Inmaculada
    Li, Huamin
    Bernstein, Jonathan
    Hsu, Connie
    Sitz, Karl
    Wieman, Lolis
    Feuer-Senger, Henrike
    Pollen, Maressa
    Reshef, Avner
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB6 - AB6
  • [37] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [38] DONIDALORSEN FOR HEREDITARY ANGIOEDEMA: RESULTS FROM THE OASISPLUS OPEN-LABEL EXTENSION STUDY
    Tachdjian, R.
    Riedl, M.
    Bordone, L.
    Newman, K.
    Treadwell, S.
    Lin, T.
    Yarlas, A.
    Cohn, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S38 - S38
  • [39] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [40] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31